富通保險:5至7月本地業務年度化保費等值錄四成增長
富通保險行政總裁楊德灝在電話會議上表示,公司在去年加入新創建集團(00659.HK),成為新世界集團成員,認為可以與對方發揮協同效應,會持續與集團各單位合作推出更多元化及突破傳統的產品。
他透露,雖然受疫情影響,但公司今年5至7月份的本地業務年度化保費等值有四成增長,有信心能維持此增速。至於內地市場則要視乎本地通關的時間,現時推出的產品主要針對本地的需求。
他又指,每次香港出現疫情的時候,客戶對於醫療保險的需求都會有所增加。有疫情期間,經紀利用網上渠道銷售的情況加劇,而能面對面會談會盡量做,公司未來亦有意設立平台銷售產品,料未來線上及線下渠道銷售會同步進行。他相信,隨著疫情持續緩和及經濟回復正常後,客戶會對保險有新需求。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.